期刊
EBIOMEDICINE
卷 82, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ebiom.2022.104179
关键词
Immunosenescence; Multiple sclerosis; Aging; T lymphocytes
资金
- EMD Serono Inc. through MS-LINK
- University of Pennsylvania
- Sanofi
- National Center for Advancing Sciences of the National Institutes of Health
- NIH/NINDS
- Parkinson Foundation
- Michael J Fox Foundation
- NIH
- NIH-NINDS
- AHA-Allen Institute
- Chan Zuckerberg Initiative Neuro-degeneration Challenge Network [TL1TR001880]
- Penn Center for Precision Medicine [K23-NS11416-01A1]
- Parker Family chair
- [R01NS112274]
- [RO1 NS115139]
In the study comparing untreated MS patients with normal controls, it was found that MS patients exhibited early and persistent redistribution of naive and memory CD4 T-cell compartments. While most CD4 and CD8 T-cell aging trajectories were similar between groups, MS patients demonstrated abnormal age-associated increases, particularly in patients over 60.
Background Immunosenescence (ISC) describes age-related changes in immune-system composition and function. Multiple sclerosis (MS) is a lifelong inflammatory condition involving effector and regulatory T-cell imbalance, yet little is known about T-cell ISC in MS. We examined age-associated changes in circulating T cells in MS compared to normal controls (NC). Methods Forty untreated MS (Mean Age 43.3, Range 18-72) and 49 NC (Mean Age 48.6, Range 20-84) without inflammatory conditions were included in cross-sectional design. T-cell subsets were phenotypically and functionally characterized using validated multiparametric flow cytometry. Their aging trajectories, and differences between MS and NC, were determined using linear mixed-effects models. Findings MS patients demonstrated early and persistent redistribution of naive and memory CD4 T-cell compartments. While most CD4 and CD8 T-cell aging trajectories were similar between groups, MS patients exhibited abnormal age-associated increases of activated (HLA-DR+CD38+; (P = 0.013) and cytotoxic CD4 T cells, particularly in patients > 60 (EOMES: P < 0.001). Aging MS patients also failed to upregulate CTLA-4 expression on both CD4 (P = 0.014) and CD8 (P = 0.009) T cells, coupled with abnormal age-associated increases in frequencies of B cells expressing costimulatory molecules. Interpretation While many aspects of T-cell aging in MS are conserved, the older MS patients harbour abnormally increased frequencies of CD4 T cells with activated and cytotoxic effector profiles. Age-related decreased expression of T-cell co-inhibitory receptor CTLA-4, and increased B-cell costimulatory molecule expression, may provide a mechanism that drives aberrant activation of effector CD4 T cells that have been implicated in progressive disease. Copyright (C) 2022 The Author(s). Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据